News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Jarushka Naidoo: Mucinous lung adenocarcinomas – clinical features and outcomes
lungcancercenter.com
Feb 26, 2025, 10:50

Jarushka Naidoo: Mucinous lung adenocarcinomas – clinical features and outcomes

Jarushka Naidoo, Full Professor and Consultant Medical Oncologist at Royal College of Surgeons in Ireland, shared a post on X about Jia Luo et al. published in Annals of Oncology:

“Mucinous lung adenocarcinomas: clinical features and outcomes Annals of Oncology:

  • Of 4082 patients with LUAD, 9.9% LUADMuc
  • associated with low PDL1 expression, low TMB
  • KRAS, NKX2-1, STK11, SMARCA4, GNAS, ALK+ seen
  • poorer PFS, OS and ORR to chemo-IO.”

“Lung adenocarcinomas with mucinous histology: clinical, genomic, and immune microenvironment characterization and outcomes to immunotherapy-based treatments and KRASG12C inhibitors”

Authors: Jia Luo et al.

Jarushka Naidoo: Mucinous lung adenocarcinomas - clinical features and outcomes

More posts featuring Jarushka Naidoo.

Annals of Oncology cancer Jarushka Naidoo Jia Luo Mucinous lung adenocarcinomas OncoDaily Oncology
Special Coverage
Insight
Feb 26, 2025, 10:50
Jarushka Naidoo: Mucinous lung adenocarcinomas - clinical features and outcomes
Blog
Feb 26, 2025, 10:49
Rizwan Jafri: Our annual Colon Cancer Awareness 5K event
Societies
Feb 26, 2025, 10:39
ESMO Guidelines Slideset on Metastatic Colorectal Cancer
Blog
Feb 26, 2025, 10:32
Nicholas DeVito: Gli2 promotes tumor immune evasion and immunotherapy resistance through Wnt and Prostaglandin signaling
Blog
Feb 26, 2025, 10:25
New Approaches Towards T Cell Receptor Engineered Cancer Immunotherapies - AACR
Career
Feb 26, 2025, 10:12
Bruna Pellini: Honored to receive the Junior Faculty Research Award for Clinical Science
Blog
Feb 26, 2025, 10:09
No evidence to suggest that CAR T cell therapy leads to secondary cancers
Science
Feb 26, 2025, 10:06
Myeloma Paper of the Day, February 26th, suggested by Robert Orlowski
Insight
Feb 26, 2025, 10:02
Hagop Kantarjian: Updated results of our frontline trial of FLAG-IDA+VEN
Blog
Feb 26, 2025, 10:01
Ravi Mehrotra: The impact of a cancer diagnosis goes far beyond the patient
Blog
Feb 26, 2025, 09:56
Cancer care is not a luxury - City Cancer Challenge
Blog
Feb 26, 2025, 09:55
Wafaa M Rashed: Pediatric Cancer Research Fund - A Battle We Cannot Afford to Lose